Beyond Type 1 Regulatory T Cells: Co-expression of LAG3 and CD49b in IL-10-Producing T Cell Lineages.

Front Immunol

Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY, United States.

Published: October 2019

Type 1 regulatory CD4 T (Tr1) cells express high levels of the immunosuppressive cytokine IL-10 but not the master transcription factor Foxp3, and can suppress inflammation and promote immune tolerance. In order to identify and obtain viable Tr1 cells for research and clinical applications, co-expression of CD49b and LAG3 has been proposed as a unique surface signature for both human and mouse Tr1 cells. However, recent studies have revealed that this pattern of co-expression is dependent on the stimulating conditions and the differentiation stage of the CD4 T cells. Here, using an IL-10/Foxp3 dual reporter transgenic murine model, we demonstrate that co-expression of CD49b and LAG3 is not restricted to the Foxp3 Tr1 cells, but is also observed in Foxp3 T regulatory (Treg) cells and CD8 T cells that produce IL-10. Our data indicate that IL-10-producing Tr1 cells, Treg cells and CD8 T cells are all capable of co-expressing LAG3 and CD49b following differentiation under IL-10-inducing conditions, and following pathogenic insult or infection in the pulmonary mucosa. Our findings urge caution in the use of LAG3/CD49b co-expression as sole markers to identify Tr1 cells, since it may mark IL-10-producing T cell lineages more broadly, including the Foxp3 Tr1 cells, Foxp3 Treg cells, and CD8 T cells.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252342PMC
http://dx.doi.org/10.3389/fimmu.2018.02625DOI Listing

Publication Analysis

Top Keywords

tr1 cells
28
cells
15
treg cells
12
cells cd8
12
cd8 cells
12
type regulatory
8
lag3 cd49b
8
il-10-producing cell
8
cell lineages
8
co-expression cd49b
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!